Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Weiss

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
American Journal of Clinical Oncology|December 1, 1994
A phase II trial of DaunoXome, liposome-encapsulated daunorubicin, in patients with metastatic adenocarcinoma of the colonJ R Eckardt, E Campbell, H A Burris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1983
Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pumpG R Weiss, M B Garnick, R T Osteen, et al.
Journal of the National Cancer Institute|September 5, 1990
Phase I study of high-dose continuous-infusion recombinant interleukin-2 and autologous lymphokine-activated killer cells in patients with metastatic or unresectable malignant melanoma and renal cell carcinomaE R Gaynor, G R Weiss, K A Margolin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimenD R Parkinson, R I Fisher, A A Rayner, et al.
Journal of Biological Response Modifiers|December 1, 1990
A phase I study of high-dose interleukin-2 in combination with interferon-alpha 2bM Sznol, J W Mier, J Sparano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group studyC G Leichman, T R Fleming, F M Muggia, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1994
A phase II clinical trial of interleukin-2 and lymphokine-activated killer cells in advanced colorectal carcinomaM J Hawkins, M B Atkins, J P Dutcher, et al.
Cancer Treatment Reviews|June 1, 1989
Review of interleukin-2 alone and interleukin-2/LAK clinical trials in metastatic malignant melanomaM Sznol, J P Dutcher, M B Atkins, et al.
Investigational New Drugs|February 1, 1993
A phase I clinical and pharmacokinetic study of the oral and the oral/intravenous administration of menogarilG R Weiss, T D Brown, J G Kuhn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapyA Y Bedikian, G R Weiss, S S Legha, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
American Journal of Clinical Oncology|December 1, 1994
A phase II trial of DaunoXome, liposome-encapsulated daunorubicin, in patients with metastatic adenocarcinoma of the colonJ R Eckardt, E Campbell, H A Burris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1983
Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pumpG R Weiss, M B Garnick, R T Osteen, et al.
Journal of the National Cancer Institute|September 5, 1990
Phase I study of high-dose continuous-infusion recombinant interleukin-2 and autologous lymphokine-activated killer cells in patients with metastatic or unresectable malignant melanoma and renal cell carcinomaE R Gaynor, G R Weiss, K A Margolin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimenD R Parkinson, R I Fisher, A A Rayner, et al.
Journal of Biological Response Modifiers|December 1, 1990
A phase I study of high-dose interleukin-2 in combination with interferon-alpha 2bM Sznol, J W Mier, J Sparano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group studyC G Leichman, T R Fleming, F M Muggia, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1994
A phase II clinical trial of interleukin-2 and lymphokine-activated killer cells in advanced colorectal carcinomaM J Hawkins, M B Atkins, J P Dutcher, et al.
Cancer Treatment Reviews|June 1, 1989
Review of interleukin-2 alone and interleukin-2/LAK clinical trials in metastatic malignant melanomaM Sznol, J P Dutcher, M B Atkins, et al.
Investigational New Drugs|February 1, 1993
A phase I clinical and pharmacokinetic study of the oral and the oral/intravenous administration of menogarilG R Weiss, T D Brown, J G Kuhn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapyA Y Bedikian, G R Weiss, S S Legha, et al.
Pageof 10